This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

proofread

Predicting no-reflow phenomenon after primary percutaneous coronary intervention in older patients with STEMI

Predicting no-reflow phenomenon after primary percutaneous coronary intervention in older patients with STEMI
ROC Curve Analysis. Credit: Cardiovascular Innovations and Applications (2023). DOI: 10.15212/CVIA.2023.0005

Coronary no-reflow phenomenon (NRP), a common adverse complication in patients with ST-segment elevation myocardial infarction (STEMI) treated by percutaneous coronary intervention (PCI), is associated with poor patient prognosis. In this study, the correlation between the systemic immune-inflammation index (SII) and NRP in older patients with STEMI was studied, to provide a basis for early identification of high-risk patients and improve their prognosis.

Between January 2017 and June 2020, 578 with acute STEMI admitted to the Department of Cardiology of Hebei General Hospital for direct PCI treatment were selected for this retrospective study. Patients were divided into an NRP group and normal-flow group according to whether NRP occurred during the operation. Clinical data and the examination indexes of the two groups were collected. Logistic regression was used to analyze the independent predictors of NRP, and the receiver operating characteristic curve was used to further analyze the ability of SII to predict NRP in older patients with STEMI.

Multivariate logistic analysis indicated that hypertension (OR=2.048, 95% CI:1.252–3.352, P=0.004), lymphocyte count (OR=0.571, 95% CI:0.368–0.885, P=0.012), platelet count (OR=1.009, 95% CI:1.005–1.013, P<0.001), hemoglobin (OR=1.015, 95% CI:1.003–1.028, P=0.018), multivessel disease (OR=2.237, 95% CI:1.407–3.558, P=0.001), and SII≥1814 (OR=3.799, 95% CI:2.190–6.593, P<0.001) were independent predictors of NRP after primary PCI in older patients with STEMI. Receiver operating characteristic curve analysis demonstrated that SII had a high predictive value for NRP (AUC=0.738; 95% CI:0.686–0.790), with the best cut-off value of 1814, a sensitivity of 52.85% and a specificity of 85.71%.

For older patients with STEMI undergoing primary PCI, SII is a valid predictor of NRP.

The work is published in the journal Cardiovascular Innovations and Applications.

More information: Jiaqi Wang et al, The Systemic Immune Inflammatory Index Predicts No-Reflow Phenomenon after Primary Percutaneous Coronary Intervention in Older Patients with STEMI, Cardiovascular Innovations and Applications (2023). DOI: 10.15212/CVIA.2023.0005

Provided by Compuscript Ltd
Citation: Predicting no-reflow phenomenon after primary percutaneous coronary intervention in older patients with STEMI (2023, February 16) retrieved 25 June 2024 from https://medicalxpress.com/news/2023-02-no-reflow-phenomenon-primary-percutaneous-coronary.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Choose life: Why patients in China refuse standard treatment for a type of heart attack

13 shares

Feedback to editors